Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Core Points - Rigel Pharmaceuticals, Inc. will report its third quarter 2025 financial results on November 4, 2025, after market close [1] - A live conference call and webcast will follow the announcement at 4:30 p.m. Eastern Time [1] - The company focuses on developing therapies for hematologic disorders and cancer [3] Financial Results Announcement - The financial results will be reported after market close on November 4, 2025 [1] - A live conference call will be held to discuss the results and provide a business update [1][2] Company Overview - Rigel Pharmaceuticals is a biotechnology company founded in 1996, based in South San Francisco, California [3] - The company is dedicated to discovering and developing novel therapies for patients with hematologic disorders and cancer [3]